The global preclinical antibacterial pipeline, Nat Rev Microbiol, 2019. ,
Combating antibiotic-resistant bacteria, 2019. ,
Translational research strategy: an essential approach to fight the spread of antimicrobial resistance, J Antimicrob Chemother, vol.69, pp.2889-91, 2014. ,
, Comité interministériel pour la santé. Maîtriser la résistance bactérienne aux antibiotiques, 2016.
,
The quality of studies evaluating antimicrobial stewardship interventions: a systematic review, Clin Microbiol Infect, vol.25, pp.555-61, 2019. ,
,
, Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors?, J Antimicrob Chemother, vol.74, issue.10, pp.2844-2851, 2019.
,
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group, Clin Microbiol Infect, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02297589
,
, recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship, vol.6, p.10134, 2016.
,
, data/ecdc-efsa-and-ema-joint-scientific-opinion-list-outcome-indicators-regards, 2019.
Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?, Euro Surveill, vol.22, issue.46, 2017. ,
, World Health Organisation. AWaRe policy brief, 2019.
,
The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance, BMJ Glob Health, vol.4, p.1838, 2019. ,
,
, Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study, Euro Surveill, issue.20, 2019.
,
, Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.59-66, 2018.
,
, Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.40-49, 2018.
Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.30-39, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02361025
,
Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.50-58, 2018. ,
Experiences of carriers of multidrugresistant organisms: a systematic review, Clin Microbiol Infect, vol.25, pp.274-283, 2019. ,
Revitalizing the antibiotic pipeline, vol.2, 2018. ,
, World Health Organisation. IACG discussion paper. Antimicrobial resistance: invest in innovation and research, and boost R&D and access, 2018.
Noninferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials, Lancet Infect Dis, vol.pii, pp.30284-30285, 2019. ,
Antibiotic pollution in the environment: from microbial ecology to public policy. Microorganisms, vol.7, 2019. ,
Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance, Antimicrob Agents Chemother, vol.55, pp.3649-60, 2011. ,
Distinguishing antimicrobial models with different resistance mechanisms via population pharmacodynamic modeling, PLoS Comput Biol, vol.12, p.1004782, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02141647
La résistance aux antibiotiques. Un enjeu de santé publique et économique, 2018. ,
Public Health Agency of Sweden. Availability of antibiotics, 2019. ,
, Department of Health and Social Care. UK government. Development of new antibiotics encouraged with new pharmaceutical payment system, 2019.
CLIN-Net maintains an up-to-date portfolio of clinical trial sites across ,
, This maximizes the efficiency of site selection and study performance for studies related to antimicrobial resistance, Europe, 2019.
Réseau national de recherche clinique en infectiologie, 2019. ,
Clinical research in intensive care and sepsis. Trial group for global evaluation and research in sepsis. F-Crin network, 2019. ,